| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |